Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia
about
Lipoprotein genotype and conserved pathway for exceptional longevity in humansApolipoprotein C3 SstI polymorphism and triglyceride levels in Asian IndiansEffects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic miceRegulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acidA targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolismMetabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteinsHeavy marijuana users show increased serum apolipoprotein C-III levels: evidence from proteomic analysesThe crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemiaExpression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditionsIn vivo role of the HNF4alpha AF-1 activation domain revealed by exon swapping.Postprandial changes in high density lipoproteins in rats subjected to gavage administration of virgin olive oilHepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasisStatins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesionJoint linkage and association analysis with exome sequence data implicates SLC25A40 in hypertriglyceridemia.Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.Liver proteomic response to hypertriglyceridemia in human-apolipoprotein C-III transgenic mice at cellular and mitochondrial compartment levelsMonogenic causes of elevated HDL cholesterol and implications for development of new therapeutics.Genetic determinants of plasma triglyceridesApolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotypeInfluence of genetic variants in the apolipoprotein A5 and C3 gene on lipids, lipoproteins, and its association with coronary artery disease in Indians.LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.Apolipoprotein A-IV regulates chylomicron metabolism-mechanism and function.Apolipoprotein CIII promotes Ca2+-dependent beta cell death in type 1 diabetes.Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetesHDL, Atherosclerosis, and Emerging TherapiesRoles of Vitamin A Metabolism in the Development of Hepatic Insulin Resistance.Impaired postprandial lipemic response in chronic kidney disease.Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice.Role of MAPK in apolipoprotein CIII-induced apoptosis in INS-1E cells.A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.The RNA-binding protein vigilin regulates VLDL secretion through modulation of Apob mRNA translationApolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets.Effect of TAK-085 on Low-density Lipoprotein Particle Size in Patients with Hypertriglyceridemia: A Double-blind Randomized Clinical Study.Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein ClChylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein ERetinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.Serum Protein KNG1, APOC3, and PON1 as Potential Biomarkers for Yin-Deficiency-Heat Syndrome.Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11.Production of apolipoprotein C-III knockout rabbits using zinc finger nucleases.Overexpression of apolipoprotein C-III decreases secretion of dietary triglyceride into lymph
P2860
Q21146060-3B378687-CCDC-4D93-BC38-8A2F242CE0EAQ21283798-6E2F6E16-4426-413E-BE2C-28AF4506883AQ24302828-CCDE6413-7418-480A-9894-508BB7F068D7Q24594113-0A407B6C-3E00-4BDE-8ACB-D4C1692D33FFQ24646308-24BC7F2B-16FF-44FB-BDFF-CDA195AC25F9Q24651503-1A29D9A7-3E44-4950-9C3F-FCDCCDE29DE2Q24654726-F9DEB42A-7CE8-468F-9EF6-CD3885711583Q26864682-0000BBCA-70A3-4C64-BD0E-E2D46FBD2106Q28252652-272D1412-5F07-404C-BE88-3F65EA0B85CCQ28506892-C7916259-AD97-4831-A229-D23D4DE718D7Q28569962-EEEF6224-8B5E-4069-8C4E-33E15C726E26Q28591211-4EB245F5-F014-4378-8B9B-C23BC5162CC5Q30536352-77D0708C-681B-4FE8-A8BC-FDF0E59D749BQ30700100-2631691D-C02B-44D1-8DFF-56919C784A11Q33727061-960E168A-3738-469D-8FF3-11AECFA958FFQ33958622-5187A473-5ABD-4D49-BB37-EDDE870E0EC7Q34441411-A82A0137-6308-4F5F-B8F2-E4ABC553B9A0Q34503333-632B2AC3-D14A-42AC-8981-91B540AE6F97Q35157797-3E34AA9C-8CBE-4CC5-89CE-0AD4272A2540Q35263542-2F4FFE4B-F66A-4C4E-A6FD-0232437B0576Q35747811-620F65CD-C95F-4B9A-A7D3-18A04224C3A8Q35849439-1601C96D-F271-4111-A6BB-BFE00F50FC75Q35971232-FA297E6D-59B6-4005-A8B7-38DB5D4F0C45Q36843331-93233BF8-DAA1-4873-BAE8-4E0A0697EF73Q36918309-CD0F22B9-04C6-4109-AA26-B078D0A85647Q36962066-8A582A90-446D-419E-B159-8DDA32D7C4CDQ37017211-FD555477-70C6-44F4-B9DA-3E1C51176579Q37078689-EFFCE3AD-8958-463D-828E-23904F0C7E52Q37109991-ADF92B70-F234-4B9A-B8BD-33E213668B41Q37171168-539F6A08-7ABB-42FC-B8E8-1BD45B7FEDA7Q37315134-1EDAED60-FBE9-486A-9934-94C971B565BDQ37333795-3F816C5E-13F2-48DF-82CE-C4DF513425B5Q37334006-4BB0A117-B682-4925-BE4A-582829793573Q37358494-E747F582-26D6-423B-8AB7-3096C3617782Q37368158-512A1EB1-46FE-4A61-9B63-A38A3A5FE976Q37384407-37F333B5-3853-486B-916B-27D06A0D95F8Q37397117-E3CF7AC6-9CFF-4CF9-90EA-77C71CB67E7BQ37408323-31779BE6-081A-4466-B134-D52A09BA73EDQ37709764-3B749ED8-BCAB-4EE2-9A4A-53B14EAEB6BFQ37727877-EAAA54CB-4ECD-4CFF-8085-87D11F635D37
P2860
Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia
description
1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1994
@ast
im September 1994 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1994/09/23)
@sk
vědecký článek publikovaný v roce 1994
@cs
wetenschappelijk artikel (gepubliceerd op 1994/09/23)
@nl
наукова стаття, опублікована у вересні 1994
@uk
name
Targeted disruption of the apo ...... tprandial hypertriglyceridemia
@ast
Targeted disruption of the apo ...... tprandial hypertriglyceridemia
@en
Targeted disruption of the apo ...... tprandial hypertriglyceridemia
@nl
type
label
Targeted disruption of the apo ...... tprandial hypertriglyceridemia
@ast
Targeted disruption of the apo ...... tprandial hypertriglyceridemia
@en
Targeted disruption of the apo ...... tprandial hypertriglyceridemia
@nl
prefLabel
Targeted disruption of the apo ...... tprandial hypertriglyceridemia
@ast
Targeted disruption of the apo ...... tprandial hypertriglyceridemia
@en
Targeted disruption of the apo ...... tprandial hypertriglyceridemia
@nl
P2093
P3181
P1476
Targeted disruption of the apo ...... tprandial hypertriglyceridemia
@en
P2093
P304
23610-23616
P3181
P407
P577
1994-09-01T00:00:00Z